Galaxy Medicare IPO

₹1,02,000/2000 shares

Minimum Investment

IPO Details

Open Date

10 Sep 25

Close Date

12 Sep 25

Minimum Investment

₹1,02,000

Lot Size

2000

Price Range

₹51 to ₹54

Listing Exchange

NSE

Issue Size

₹22.31 Cr

Listing Date

17 Sep 25

Open Free Demat Account

Galaxy Medicare IPO Timeline

Bidding Start

10 Sep 25

Bidding Ends

12 Sep 25

Allotment Finalisation

15 Sep 25

Refund Initiation

16 Sep 25

Demat Transfer

16 Sep 25

Listing

17 Sep 25

Galaxy Medicare Limited

Incorporated in July 1992, Galaxy Medicare Limited manufactures and exports medical devices, POP bandages, and surgical dressings in India, using premium-grade raw materials from authentic vendors. The company offers a wide range of products, including surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, wound care solutions, gauze products, and orthopedic items. It operates through flagship brands, OEM manufacturing, government tenders, and exports, holding 27 registered trademarks. ISO 9001:2015 and ISO 13485:2016 certifications ensure quality compliance, and as of March 2025, it employs 190 professionals across departments.

Galaxy Medicare Limited IPO Overview

Galaxy Medicare IPO is a book building issue worth ₹22.31 crores, comprising a fresh issue of 0.33 crore shares aggregating ₹17.86 crores and an offer for sale of 0.08 crore shares aggregating ₹4.45 crores. The IPO opens for subscription on 10 September 2025 and closes on 12 September 2025, with allotment expected on 15 September 2025 and a tentative listing on NSE SME on 17 September 2025. The price band is ₹51 to ₹54 per share, with a lot size of 2,000 shares. Retail investors must invest a minimum of ₹2,16,000 for 4,000 shares, while HNIs require a minimum of 3 lots (6,000 shares) amounting to ₹3,24,000. Affinity Global Capital Market Pvt. Ltd. is the book running lead manager, Cameo Corporate Services Ltd. is the registrar, and Prabhat Financial Services Ltd. is the market maker.

Galaxy Medicare Limited IPO Details

Particulars	Details
IPO Date	10 September 2025 to 12 September 2025
Listing Date	17 September 2025
Face Value	₹10 per share
Issue Price Band	₹51 to ₹54 per share
Lot Size	2,000 Shares
Total Issue Size	41,32,000 shares (aggregating up to ₹22.31 Cr)
Fresh Issue	31,00,000 shares (aggregating up to ₹16.74 Cr)
Offer for Sale	8,24,000 shares (aggregating up to ₹4.45 Cr)
Issue Type	Bookbuilding IPO
Listing At	NSE SME
Share Holding Pre Issue	1,18,63,983 shares
Share Holding Post Issue	1,51,71,983 shares
Market Maker Portion	2,08,000 shares

Galaxy Medicare IPO Reservation

Investor Category	Shares Offered
Market Maker	2,08,000 (5.03%)
QIB	80,000 (1.94%)
NII (HNI)	15,36,000 (37.17%)
Retail	23,08,000 (55.86%)

Galaxy Medicare IPO Lot Size

Application	Lots	Shares	Amount
Retail (Min)	2	4,000	₹2,16,000
Retail (Max)	2	4,000	₹2,16,000
HNI (Min)	3	6,000	₹3,24,000
HNI (Max)	9	18,000	₹9,72,000
B-HNI (Min)	10	20,000	₹10,80,000

Galaxy Medicare IPO Promoter Holding

Shareholding Status	Percentage
Pre-Issue	89.49%
Post-Issue	64.60%

Galaxy Medicare Limited IPO Valuation Overview

KPI	Value
Earnings Per Share (EPS)	2.84 (Pre IPO), 2.22 (Post IPO)
Price/Earnings (P/E) Ratio	19.01 (Pre IPO), 24.31 (Post IPO)
Return on Net Worth (RoNW)	18.35%
Net Asset Value (NAV)	14.06
Return on Equity	19.88%
Return on Capital Employed (ROCE)	22.38%
EBITDA Margin	11.69%
PAT Margin	8.60%
Debt to Equity Ratio	0.25

Objectives of the Proceeds

Purchase machinery for the existing manufacturing facility in Bhubaneshwar, Odisha: ₹4.89 Cr

Fund working capital requirements: ₹8.94 Cr

General corporate purposes

Meet IPO-related expenses

Key Financials (₹ Crore)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	31.49	32.53	32.31
Revenue	40.27	36.94	32.03
Profit After Tax	3.37	3.71	1.57
Reserves and Surplus	12.29	9.51	14.78
Total Borrowings	4.61	8.12	9.15

SWOT Analysis of Galaxy Medicare IPO

Strength and Opportunities

Strong leadership team with extensive industry experience.
Well-established manufacturing and quality control processes.
Diverse product portfolio meeting various medical needs.
Growing international market presence for exports.

Risks and Threats

High dependency on specific domestic suppliers for raw materials.
Limited international brand recognition compared to global competitors.
Regulatory changes may impact product approvals and exports.
Competitive pricing pressures in the domestic medical devices market.

Explore IPO Opportunities

Explore our comprehensive IPO pages to stay updated on the latest trends and insights.

Upcoming SME IPOs

Current SME IPOs

Closed SME IPOs

About Galaxy Medicare Limited

Galaxy Medicare IPO Strengths

Experienced leadership and skilled management team ensures efficient operations.

Established reputation and strong customer relationships across domestic and international markets.

Focus on consistently meeting high-quality standards for products and processes.

Well-established manufacturing facility with a wide range of medical and surgical products.

In-house Quality Assurance (QA)/Quality Control (QC) and R&D strengthen product reliability.

Strong international presence with exports to multiple countries enhancing revenue streams.

Peer Comparison

Company Name	EPS (Basic)	EPS (Diluted)	NAV (per share)	P/E (x)	RoNW (%)	P/BV Ratio
Galaxy Medicare	2.84	2.84	14.06	19.01	18.35	3.49
Peer Group
Adeshwar Meditex	1.43	1.43	27.69	12.59	5.17	0.67
KMS Medisurgi	1.33	1.33	24.50	95.11	5.44	5.25

How to apply IPO with HDFC SKY?

Follow these simple steps to apply for an IPO through HDFC SKY. Secure your investments and explore new opportunities with ease by accessing the IPOs available on the platform.

1Login to your HDFC SKY Account

2Select Issue

3Enter Number of Lots and your Price.

4Enter UPI ID

5Complete Transaction on Your UPI App